TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether giving tranexamic acid to patients receiving
treatment for blood cancers reduces the risk of bleeding or death, and the need for platelet
transfusions. Patients will be randomised to receive tranexamic acid (given intravenously
through a drip, or orally) or a placebo.
Phase:
Phase 3
Details
Lead Sponsor:
NHS Blood and Transplant
Collaborators:
Monash University National Health and Medical Research Council, Australia